Toll Free: 1-888-928-9744

Kaken Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014

Published: Dec, 2014 | Pages: 32 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Kaken Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Kaken Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014', provides an overview of the Kaken Pharmaceutical Co., Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Kaken Pharmaceutical Co., Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Kaken Pharmaceutical Co., Ltd. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Kaken Pharmaceutical Co., Ltd.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Kaken Pharmaceutical Co., Ltd.'s pipeline products

Reasons to buy

- Evaluate Kaken Pharmaceutical Co., Ltd.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Kaken Pharmaceutical Co., Ltd. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Kaken Pharmaceutical Co., Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Kaken Pharmaceutical Co., Ltd. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Kaken Pharmaceutical Co., Ltd.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Kaken Pharmaceutical Co., Ltd. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Kaken Pharmaceutical Co., Ltd. Snapshot 5
Kaken Pharmaceutical Co., Ltd. Overview 5
Key Information 5
Key Facts 5
Kaken Pharmaceutical Co., Ltd. - Research and Development Overview 6
Key Therapeutic Areas 6
Kaken Pharmaceutical Co., Ltd. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Partnered Products 10
Partnered Products/Combination Treatment Modalities 11
Kaken Pharmaceutical Co., Ltd. - Pipeline Products Glance 12
Kaken Pharmaceutical Co., Ltd. - Late Stage Pipeline Products 12
Phase III Products/Combination Treatment Modalities 12
Kaken Pharmaceutical Co., Ltd. - Clinical Stage Pipeline Products 13
Phase II Products/Combination Treatment Modalities 13
Phase I Products/Combination Treatment Modalities 14
Kaken Pharmaceutical Co., Ltd. - Early Stage Pipeline Products 15
Preclinical Products/Combination Treatment Modalities 15
Kaken Pharmaceutical Co., Ltd. - Drug Profiles 16
trafermin 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
KCB-1B 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
KAG-308 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
S-101479 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
S-40542 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
Small Molecules to Target Androgen Receptor for Osteoporosis 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Kaken Pharmaceutical Co., Ltd. - Pipeline Analysis 23
Kaken Pharmaceutical Co., Ltd. - Pipeline Products by Target 23
Kaken Pharmaceutical Co., Ltd. - Pipeline Products by Route of Administration 24
Kaken Pharmaceutical Co., Ltd. - Pipeline Products by Molecule Type 25
Kaken Pharmaceutical Co., Ltd. - Pipeline Products by Mechanism of Action 26
Kaken Pharmaceutical Co., Ltd. - Recent Pipeline Updates 27
Kaken Pharmaceutical Co., Ltd. - Dormant Projects 28
Kaken Pharmaceutical Co., Ltd. - Discontinued Pipeline Products 29
Discontinued Pipeline Product Profiles 29
KP-496DPI 29
KP-413 29
KP-496NS 29
Pralmorelin dihydrochloride 29
SPK-843 29
Kaken Pharmaceutical Co., Ltd. - Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Appendix 31
Methodology 31
Coverage 31
Secondary Research 31
Primary Research 31
Expert Panel Validation 31
Contact Us 32
Disclaimer 32
List of Tables
Kaken Pharmaceutical Co., Ltd., Key Information 5
Kaken Pharmaceutical Co., Ltd., Key Facts 5
Kaken Pharmaceutical Co., Ltd. - Pipeline by Indication, 2014 7
Kaken Pharmaceutical Co., Ltd. - Pipeline by Stage of Development, 2014 8
Kaken Pharmaceutical Co., Ltd. - Monotherapy Products in Pipeline, 2014 9
Kaken Pharmaceutical Co., Ltd. - Partnered Products in Pipeline, 2014 10
Kaken Pharmaceutical Co., Ltd. - Partnered Products/ Combination Treatment Modalities, 2014 11
Kaken Pharmaceutical Co., Ltd. - Phase III, 2014 12
Kaken Pharmaceutical Co., Ltd. - Phase II, 2014 13
Kaken Pharmaceutical Co., Ltd. - Phase I, 2014 14
Kaken Pharmaceutical Co., Ltd. - Preclinical, 2014 15
Kaken Pharmaceutical Co., Ltd. - Pipeline by Target, 2014 23
Kaken Pharmaceutical Co., Ltd. - Pipeline by Route of Administration, 2014 24
Kaken Pharmaceutical Co., Ltd. - Pipeline by Molecule Type, 2014 25
Kaken Pharmaceutical Co., Ltd. - Pipeline Products by Mechanism of Action, 2014 26
Kaken Pharmaceutical Co., Ltd. - Recent Pipeline Updates, 2014 27
Kaken Pharmaceutical Co., Ltd. - Dormant Developmental Projects,2014 28
Kaken Pharmaceutical Co., Ltd. - Discontinued Pipeline Products, 2014 29
Kaken Pharmaceutical Co., Ltd., Subsidiaries 30 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify